The Core Center for Gene Therapy at the University of Washington School of Medicine (UWSM) is under the direction of A. Dusty Miller, Ph.D. (Program Director), Affiliate Professor of Pathology and a Member of the Fred Hutchinson Cancer Research Center, and Associate Program Director Bonnie W. Ramsey, M.D., Professor of Pediatrics. The Center brings together gene therapy research efforts at UWSM, the Fred Hutchinson Cancer Research Center, Children's Hospital and Medical Center in Seattle, and the Veteran's Administration Medical Center, and includes close ties with the Cystic Fibrosis Research Program headed by Dr. Bonnie Ramsey, the General Clinical Research Center (GCRC) headed by John Brunzell, M.D., and the Program of Excellence in Gene Therapy (PEGT) headed by George Stamatoyannopoulos, M.D., Dr.Sci. The Center will focus on three main areas of research: 1) development of viral vectors and procedures for the treatment of cystic fibrosis, 2) development of retroviral vectors for gene transfer and expression of therapeutic genes in hematopoietic and lymphoid cells in humans, and 3) development of methods to deliver circulating proteins such as erythropoietin and cytokines for treatment of human disease. A total of 52 investigators who receive over $27 million in independent external support will regularly use the core facilities and collaborate in development of gene therapy protocols. This work will be supported by an Administrative Component and seven other core facilities: Human Applications Core, three Vector Cores, Immunohistochemistry Core, Hematopoietic Cell Transduction Core, and Animal Core. In addition, the Pilot and Feasibility program will consist [sic] 2 projects which are directed towards gene therapy. The Pilot and Feasibility projects currently include: 1) New Helper-dependent Adenovirus Vectors Based on Serotype 11 for Stable Gene transfer into Airway Epithelial Cells; PI: Andre Lieber, MD, PhD; and 2) Foamy Virus Vectors for Gene therapy of rag1 and rag2 Deficiency of a Mouse Model of the Human Disease; PI: George Vassilopoulos, MD, PhD.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (O1))
Program Officer
Mckeon, Catherine T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Murnane, R; Zhang, X B; Hukkanen, R R et al. (2011) Myelodysplasia in 2 pig-tailed macaques (Macaca nemestrina) associated with retroviral vector-mediated insertional mutagenesis and overexpression of HOXB4. Vet Pathol 48:999-1001
Metzger, Michael J; McConnell-Smith, Audrey; Stoddard, Barry L et al. (2011) Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res 39:926-35
Miller, A D; Metzger, M J (2011) APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines. Gene Ther 18:528-30
Halbert, C L; Metzger, M J; Lam, S-L et al. (2011) Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production. Gene Ther 18:411-7
Kiem, Hans-Peter; Ironside, Christina; Beard, Brian C et al. (2010) A retroviral vector common integration site between leupaxin and zinc finger protein 91 (ZFP91) observed in baboon hematopoietic repopulating cells. Exp Hematol 38:819-22, 822.e1-3
Trobridge, Grant D; Wu, Robert A; Hansen, Michael et al. (2010) Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol Ther 18:725-33
Becker, P S; Taylor, J A; Trobridge, G D et al. (2010) Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. Gene Ther 17:1244-52
Doty, Raymond T; Sabo, Kathleen M; Chen, Jing et al. (2010) An all-feline retroviral packaging system for transduction of human cells. Hum Gene Ther 21:1019-27
Enssle, Joerg; Trobridge, Grant D; Keyser, Kirsten A et al. (2010) Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors. Hum Gene Ther 21:397-403
Halbert, Christine L; Madtes, David K; Vaughan, Andrew E et al. (2010) Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Mol Ther 18:1165-72

Showing the most recent 10 out of 176 publications